Sodium dl-α-tocopheryl-6-O-phosphate inhibits PGE₂ production in keratinocytes induced by UVB, IL-1β and peroxidants.
Eiko Kato, Yuichi Sasaki, Noriko Takahashi
Index: Bioorg. Med. Chem. 19 , 6348-55, (2011)
Full Text: HTML
Abstract
The water-soluble vitamin E derivative, sodium dl-α-tocopheryl-6-O-phosphate (1), exhibits protective effects against skin damage. As reported herein, we investigated the actions of 1 on the formation of the inflammatory mediator, prostaglandin E(2) (PGE(2)), as compared to dl-α-tocopheryl acetate (2) and dipotassium glycyrrhizin acid (3). In a three-dimensional (3D) human skin model 1 was converted to α-tocopherol (Toc) to a greater extent than 2. Post-treatment using 2% 1 following ultraviolet B (UVB) irradiation for 2h significantly reduced photodamage as indicated by UVB-damaged cell formation and PGE(2) synthesis. In normal human epidermal keratinocytes stimulated with UVB irradiation, or exposed to interleukin-1 beta, tert-butylhydroperoxide or hydrogen peroxide, pre-treatment with 1 (0-2 μM) inhibited PGE(2) production in dose-dependent manner to a greater extent than 2 and 3. Increases in stimulator-induced cyclooxygenase 2 mRNA expression and p38 MAPK phosphorylation were suppressed by pre-treatment with 1. The vitamin C derivative, magnesium L-ascorbyl-2-phosphate, significantly and synergistically, enhanced the inhibitory effects of 1 on PGE(2) production. These results suggest that 1 is a highly potent protective when compared among the examined commercial human skin care products, and that it might be useful for therapeutic and preventive medicine.Copyright © 2011 Elsevier Ltd. All rights reserved.
Related Compounds
Related Articles:
2010-01-01
[Chem. Res. Toxicol. 23 , 171-83, (2010)]
2013-01-01
[PLoS ONE 8(1) , e47448, (2013)]
Preparation of alginate beads containing a prodrug of diethylenetriaminepentaacetic acid.
2013-02-15
[Carbohydr. Polym. 92(2) , 1915-20, (2013)]
Phytantriol-based in situ liquid crystals with long-term release for intra-articular administration.
2015-08-01
[AAPS PharmSciTech 16 , 846-54, (2015)]
2015-03-01
[Pharm. Dev. Technol. 20(2) , 211-8, (2015)]